Simvastatin + Voclosporin
Phase 1Completed 0 watching 0 views this week๐ค Quiet
28
Development Stage
โ
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Drug-drug Interaction
Conditions
Drug-drug Interaction
Trial Timeline
Jan 24, 2022 โ Apr 5, 2022
NCT ID
NCT05306379About Simvastatin + Voclosporin
Simvastatin + Voclosporin is a phase 1 stage product being developed by Aurinia Pharmaceuticals for Drug-drug Interaction. The current trial status is completed. This product is registered under clinical trial identifier NCT05306379. Target conditions include Drug-drug Interaction.
Hype Score Breakdown
Clinical
10
Activity
5
Company
5
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05306379 | Phase 1 | Completed |
Competing Products
15 competing products in Drug-drug Interaction